Thrombophlebitis with intravenous naftidrofuryl oxalate.
D004340:Drug Contamination / Q000517:prevention & control; D005663:Furans / Q000031:analogs & derivatives*; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects; D009257:Nafronyl / Q000009:adverse effects / Q000031:analogs & derivatives*; D013924:Thrombophlebitis / Q000209:etiology*
D005663:Furans; D009257:Nafronyl